Elucidating Treg Dysregulation Due to IL-2 Deprivation in SLE & Other Rheumatic Diseases

Time: 3:00 pm
day: Pre-Conference Focus Day


  • Understanding the pathophysiological relevance and characteristics of Treg dysregulation in rheumatic diseases
  • Dissecting the central role of acquired IL-2 deficiency in promoting Treg exhaustion and disease acceleration in SLE and other autoimmune diseases
  • Providing the clinical proof-of-concept for the use of low-dose IL-2 therapy aiming to restore Treg homeostasis in SLE